Translational Immunologist studying the cross talk between innate and adaptive immunity in tumor immunity @genentech; mother; daughter; wife; traveler.
Foster City, CA
Joined September 2019
- Tweets26
- Following231
- Followers83
- Likes170
Shomyseh Sanjabi retweeted
Repurpose T cell self-reactivity for #cancer #immunosurveillance . Check out our new study @Nature by brilliant @CancerResearch fellows Chun Chou and @XianZhang2016 with help from @chirag_msk @JoshSmithMDPhD and other @MSKCancerCenter colleagues. rdcu.be/cLLaG
Thank you @ImmunoInsights for this great interview and allowing us to share some of our insights in this exciting area!
Watch “Leveraging cutting edge tools to convert I-O data into knowledge” on #Vimeo vimeo.com/629081913
Shomyseh Sanjabi retweeted
At end of life, woman, 44, with ovarian cancer urges others to know symptoms today.com/health/woman-termi… via @TODAYshow
Ovarian cancer symptoms in addition to the ones I experienced are described here.
Proud to be part of an amazing biomarker team @genentech and having the opportunity to do this important work for our cancer patients!
Proud of the work @shomyseh is doing on the immune monitoring front to better understand MoA novel Immunotherapies @genentech
Excited to be part of this session and highlight some of the high complexity immune monitoring that we have been doing in early stage clinical trials!
#FlowICCS21 Tuesday 10/12/21, 8:30-11:20 AM
Plenary Session 4: HIT ME WITH YOUR BEST SHOT: IMMUNE MONITORING PLAYS CENTER FIELD
@VirginiaLitwin, @srishtigpath, @shomyseh, @s_apostolidis, @kathrynfoulds, @PennMDForum will discuss immune monitoring #vaccines and #flowcytometry
Shomyseh Sanjabi retweeted
Prof Deonandan was asked by a student journalist what he would say to the 20% of polled uOttawa students who complain that our campus's vaccine requirements are an "infringement on their rights of free movement." His response:
Shomyseh Sanjabi retweeted
Scientists have long known that cancer cells and immune cells have an uncommon hunger for glucose but haven’t understood why. A new study led by MSK immunologist Ming Li offers an answer. @ScienceMagazine bit.ly/392y3T1
Shomyseh Sanjabi retweeted
We are delighted to announce the amazing speakers for the #globalimmuno talks scheduled until December 2020!
We also encourage everyone to subscribe & enjoy the phenomenal previous talks in YouTube
youtube.com/c/GLOBALIMMUNOTA…
Updates at labs.biology.ucsd.edu/zuniga…
Please distribute🙏
Shomyseh Sanjabi retweeted
Congratulations to Richard A. Flavell, PhD, Sterling Professor of Immunobiology and a Howard Hughes Medical Institute investigator, who's been named a Distinguished Fellow by the American Association of Immunologists (AAI) medicine.yale.edu/news-artic…
Shomyseh Sanjabi retweeted
#Breaking: Our #immunotherapy combination is the first to demonstrate positive overall survival and progression-free survival in a Phase III study for people with the most common form of #livercancer gene.com/media/press-release…
Shomyseh Sanjabi retweeted
Zeyu Chen's new paper in Immunity identifies early precursors of Exhausted T cells and identifies underlying molecular circuitry. Helps clarify the developmental trajectories of Tex and relationship of Tex Precursors, Progenitor and terminal Tex subsets. cell.com/immunity/fulltext/S…
So proud of my former trainees Shahzada Khan and Irene Lew for their tireless efforts on getting this published! rdcu.be/bRRJo
ZIKV takes advantage of multiple windows of opportunities in the female reproductive tract naturemicrobiologycommunity.… #behindthepaper